Edition:
United Kingdom

Biohaven Pharmaceutical Holding Company Ltd (BHVN.N)

BHVN.N on New York Stock Exchange

37.96USD
3:52pm BST
Change (% chg)

$-0.22 (-0.56%)
Prev Close
$38.17
Open
$38.05
Day's High
$38.32
Day's Low
$37.65
Volume
14,015
Avg. Vol
200,450
52-wk High
$67.86
52-wk Low
$29.17

Select another date:

Sat, Jul 20 2019

Photo

Biohaven's treatment for Lou Gehrig's disease fails to win FDA nod

Biohaven Pharmaceutical Holding Co Ltd said on Friday the U.S. health regulator failed to approve its treatment for amyotrophic lateral sclerosis, or Lou Gehrig's disease, sending its shares down nearly 6% in extended trading.

Biohaven's treatment for Lou Gehrig's disease fails to win FDA nod

July 19 Biohaven Pharmaceutical Holding Co Ltd said on Friday the U.S. health regulator failed to approve its treatment for amyotrophic lateral sclerosis, or Lou Gehrig's disease, sending its shares down nearly 6% in extended trading.

Select another date: